May 21 – 23, 2024 | Boston, MA

With a whopping 7 approvals in the last two years, the field is alive with positive clinical readouts and the drive to get more life-changing cell engager therapeutics to patients in indications of huge unmet need.

The timely 6th Cell Engager Therapeutics Summit is back once again to meet the needs of the community, focused on reaching new indications by expanding the target space and focusing our content on novel targets as well as continuing the push to focus on the translational challenges of developing cell engager therapies for solid and liquid tumors.

This is your one-stop shop for all of the must-have content dedicated to all engagers such as T-cell engagers, BiTe’s, gamma delta engagers and NK engages. Join Beacon and our expert Research Analyst, Flavio Lima Bianchi, as he maps out the past, present & future of cell engager therapies. Find out the full Day 2 opening presentation details here.